EE03665B1 - Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks - Google Patents

Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks

Info

Publication number
EE03665B1
EE03665B1 EE9800295A EE9800295A EE03665B1 EE 03665 B1 EE03665 B1 EE 03665B1 EE 9800295 A EE9800295 A EE 9800295A EE 9800295 A EE9800295 A EE 9800295A EE 03665 B1 EE03665 B1 EE 03665B1
Authority
EE
Estonia
Prior art keywords
prevention
nasal spray
spray formulation
delayed emesis
metoclopramide nasal
Prior art date
Application number
EE9800295A
Other languages
English (en)
Other versions
EE9800295A (et
Inventor
Psilogenis Mary
Original Assignee
Ribogene, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene, Inc. filed Critical Ribogene, Inc.
Publication of EE9800295A publication Critical patent/EE9800295A/et
Publication of EE03665B1 publication Critical patent/EE03665B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9800295A 1996-03-14 1997-03-13 Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks EE03665B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,121 US5760086A (en) 1996-03-14 1996-03-14 Nasal administration of agents for treatment of delayed onset emesis
PCT/US1997/003974 WO1997033573A1 (en) 1996-03-14 1997-03-13 Nasal administration of agents for treatment of delayed onset emesis

Publications (2)

Publication Number Publication Date
EE9800295A EE9800295A (et) 1999-02-15
EE03665B1 true EE03665B1 (et) 2002-04-15

Family

ID=24468120

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800295A EE03665B1 (et) 1996-03-14 1997-03-13 Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks

Country Status (24)

Country Link
US (1) US5760086A (et)
EP (1) EP0891186B1 (et)
JP (1) JP2000507234A (et)
KR (1) KR100420673B1 (et)
CN (1) CN1217657A (et)
AT (1) ATE489137T1 (et)
AU (1) AU707467B2 (et)
BG (1) BG102780A (et)
CA (1) CA2248968C (et)
CZ (1) CZ289797B6 (et)
DE (1) DE69740060D1 (et)
DK (1) DK0891186T3 (et)
EE (1) EE03665B1 (et)
ES (1) ES2357520T3 (et)
IL (1) IL126199A (et)
NO (1) NO984245L (et)
NZ (1) NZ331991A (et)
PL (1) PL328940A1 (et)
PT (1) PT891186E (et)
RU (1) RU2181588C2 (et)
SK (1) SK282695B6 (et)
UA (1) UA57733C2 (et)
WO (1) WO1997033573A1 (et)
YU (1) YU40398A (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
CN102209470B (zh) * 2008-11-11 2013-03-13 荷兰联合利华有限公司 茶组合物
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CA3155873C (en) 2008-12-22 2024-03-19 Evoke Pharma, Inc. Nasal formulations of metoclopramide
US20110165143A1 (en) * 2010-01-06 2011-07-07 The Regents Of The University Of Colorado, A Body Corporate Modulation of caspases and therapeutical applications
PL2747561T3 (pl) 2011-08-25 2018-11-30 Evoke Pharma, Inc. Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej
FR2980976B1 (fr) 2011-10-10 2015-10-16 Mohamed Skiba Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
CN104606136A (zh) * 2015-01-06 2015-05-13 中国人民解放军军事医学科学院毒物药物研究所 甲氧氯普胺鼻腔喷雾剂、其制备方法及用途
EP3554489A4 (en) 2016-12-15 2020-06-17 Evoke Pharma, Inc. TREATMENT OF MODERATE AND SERIOUS GASTROPARESIS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same

Also Published As

Publication number Publication date
IL126199A0 (en) 1999-05-09
KR19990087763A (ko) 1999-12-27
CZ292298A3 (cs) 1999-03-17
WO1997033573A1 (en) 1997-09-18
IL126199A (en) 2004-06-01
KR100420673B1 (ko) 2004-07-23
AU2210297A (en) 1997-10-01
RU2181588C2 (ru) 2002-04-27
CN1217657A (zh) 1999-05-26
CA2248968A1 (en) 1997-09-18
US5760086A (en) 1998-06-02
NO984245D0 (no) 1998-09-14
NZ331991A (en) 2000-04-28
UA57733C2 (uk) 2003-07-15
AU707467B2 (en) 1999-07-08
CA2248968C (en) 2005-08-02
SK125998A3 (en) 1999-03-12
PT891186E (pt) 2011-02-25
BG102780A (en) 2000-01-31
DK0891186T3 (da) 2011-03-14
EP0891186A1 (en) 1999-01-20
EP0891186B1 (en) 2010-11-24
YU40398A (sh) 2001-07-10
JP2000507234A (ja) 2000-06-13
NO984245L (no) 1998-11-11
ES2357520T3 (es) 2011-04-27
EP0891186A4 (en) 2004-03-31
EE9800295A (et) 1999-02-15
PL328940A1 (en) 1999-03-01
ATE489137T1 (de) 2010-12-15
CZ289797B6 (cs) 2002-04-17
SK282695B6 (sk) 2002-11-06
DE69740060D1 (de) 2011-01-05

Similar Documents

Publication Publication Date Title
HRP20000292B1 (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
MX9302867A (es) Composiciones refrescantes.
DE69827777D1 (de) Zusammensetzungen mit verzögerter Wirkstoffabgabe zur Behandlung der Hyperlipidämie
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
NO953262L (no) Bedring av Dupuytrens sykdom
EE03665B1 (et) Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks
ZA986673B (en) Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders
AU7728691A (en) Use of substituted beta-hydroxyethylamines as potent inhibitors of the exoenzymes of fungi
EP0992243A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
ID27184A (id) Sistem dan metode untuk memproduksi suatu catatan yang tidak dipengaruhi oleh efek bahu dan landaian yang dikembangkan oleh suatu perkakas
ES2128112T3 (es) Nuevas composiciones herbicidas.
AU2417995A (en) Use of no scavengers, inhibitors or antagonists in the treatment of migraine
MX9804589A (es) Composiciones blanqueadoras para aspersion, con irritacion respiratoria reducida.
BG101526A (en) Antiphlogistic composition for external application
MX9300601A (es) Compuestos de arilalcoxifenoxi-imidazolina.
MX9909548A (es) Metodos para la reduccion de fibrinogenos.
MX9804586A (es) Uso de una composicion acida para la suavidad mejorada a la piel.
ITAQ920005A0 (it) Consolidamento e ripristino "torre di pisa"
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
DE59911958D1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20050313